The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: US tech titans, AstraZeneca in focus

Wed, 29th Jul 2020 16:19

(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.




But the US economy won't be far from investors minds either, as the Commerce Department releases second quarter US gross domestic product data that economists at Barclays Research anticipate will show an annualised 35% drop in activity.

Some analysts believe that their updates may well set the tone for over the entire month of August.

In the UK on the other hand, the only noteworthy release will be for motor vehicle production in June.

Across the Channel meanwhile, readings are due out for monthly unemployment in Germany and Italy, alongside second quarter GDP readings in Austria, Belgium and Germany.



The earnings calendar for the UK is full on Thursday

In the case of AstraZeneca, UBS analyst Michael Leuchten sees first half revenues coming in at $6.33bn (consensus: $6.25bn) and core earnings per share at $0.93 (consensus: $0.92).

Focus would be on the drugmaker's work on a Covid-19 vaccine alongside Oxford University, which was currently considered the front-runner in the global race to find a vaccine.

But concerns around cash generation were likely to resurface as well.

"Top-line momentum remains key for investors, in particular Tagrisso (UBSe of $1,013m vs cons. $1,031m), Lynparza (UBSe of $460m vs cons. $412m) and Imfinzi (UBSe $478m vs cons $465m). Calquence uptake will be of interest (UBSe of $102m vs cons. $103m). We will also look for any commentary around COVID-19 potential impact in H2 and the path to recovery."

Thursday 29 July

FINALS

The Panoply Holdings

INTERIMS

SEGRO, Kcell Joint Stock Co GDR (Reg S), BAE Systems, Franchise Brands, Greencoat UK Wind, Hutchison China Meditech Ltd, Inchcape, Robert Walters, Rentokil Initial, Goco Group, Schroders, AstraZeneca

Q2

Schroders, AstraZeneca, Royal Dutch Shell 'A', Royal Dutch Shell 'B'

TRADING ANNOUNCEMENTS

Compass Group, Gem Diamonds Ltd. (DI), Evraz, Volution Group

AGMs

Norcros, Card Factory, OnTheMarket, BMO Global Smaller Companies, Highland Gold Mining Ltd., Volex, London & Associated Properties, TMT Investments, Angling Direct, Gabelli Value Plus Trust, Stobart Group Ltd.

FINAL EX-DIVIDEND DATE

Anexo Group, Ventus 2 VCT 'C' Shares, Monks Inv Trust, Ventus VCT, Ventus 2 VCT D Shs, Keller Group, Ventus 2 VCT, Ventus VCT D Shs

FINAL DIVIDEND PAYMENT DATE

Anglo Asian Mining

INTERIM EX-DIVIDEND DATE

Investment Company, Hansa Investment Company Limited (DI), Aberdeen Asian Income Fund Ltd., BB Healthcare Trust (Red), Hansa Investment Company Limited 'A' Non Vtg (DI), Independent Inv Trust, Secure Income Reit, RELX plc, Nichols, Blackstone/GSO Loan Financing Limited, Blackrock Throgmorton Trust, GCP Infrastructure Investments Ltd, Aew UK Reit, Value and Income Trust, Henderson International Income Trust, Maven Income and Growth VCT 5, Schroder Real Estate Investment Trust Ltd, Starwood European Real Estate Finance Ltd, GCP Asset Backed Income Fund Limited, Henderson Far East Income Ltd., Maven Income & Growth 3 VCT, Foresight Solar Fund Limited, Ecofin Global Utilities and Infrastructure Trust

INTERIM DIVIDEND PAYMENT DATE

Robinson

SPECIAL EX-DIVIDEND DATE

Keller Group

QUARTERLY EX-DIVIDEND DATE

Marble Point Loan Financing Limited NPV, SME Credit Realisation Fund Limited NPV, City of London Inv Trust

QUARTERLY PAYMENT DATE

Real Estate Credit Investments Ltd

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Unemployment Rate (GER) (08:55)

GDP (Preliminary) (GER) (09:00)

Business Climate Indicator (EU) (10:00)

Industrial Confidence (EU) (10:00)

Economic Sentiment Indicator (EU) (10:00)

Unemployment Rate (EU) (10:00)

Services Sentiment (EU) (10:00)

Services Confidence (EU) (10:00)

GDP (Preliminary) (US) (13:30)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)



More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.